STING1 and neoplasm: Activation of type I IFN raised importance in the context of cancer as an anti-tumorigenic mechanism of the cell, leading to immunosurveillance: Detection of tumor-derived DNA by innate immune sensors and cGAS-dependent activation of STING leads to type I IFN secretion (105, 106).